These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30659917)

  • 1. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
    Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
    Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
    Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
    J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
    Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
    Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
    Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
    Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
    J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine attenuates ferroptosis by Keap1-Nrf2/HO-1 pathway in LPS-induced acute kidney injury.
    Luo RR; Yang J; Sun YL; Zhou BY; Zhou SX; Zhang GX; Yang AX
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7785-7796. PubMed ID: 38722344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
    Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
    Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine Inhibits TLR4/NF-κB Activation and Reduces Acute Kidney Injury after Orthotopic Autologous Liver Transplantation in Rats.
    Yao H; Chi X; Jin Y; Wang Y; Huang P; Wu S; Xia Z; Cai J
    Sci Rep; 2015 Nov; 5():16849. PubMed ID: 26585410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
    Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
    Kiyonaga N; Moriyama T; Kanmura Y
    Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice.
    Liu Y; Yu Y; Zhang J; Wang C
    Life Sci; 2019 Dec; 239():116868. PubMed ID: 31682847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
    Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ
    Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
    Bao N; Tang B; Wang J
    J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase.
    Zhang X; Wang J; Qian W; Zhao J; Sun L; Qian Y; Xiao H
    Neurol Res; 2015 Mar; 37(3):238-45. PubMed ID: 25082544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
    Li Q; Chen C; Chen X; Han M; Li J
    Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
    Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
    Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats.
    Zhang H; Sha J; Feng X; Hu X; Chen Y; Li B; Fan H
    Int Immunopharmacol; 2019 Sep; 74():105717. PubMed ID: 31254953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
    Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.